Publisher
Springer Berlin Heidelberg
Reference274 articles.
1. Adami S, Salvagno G, Guarrera G, Bianchi G, Dorizzi R, Rosini S, Morbiljo G, Lo Casco V (1985) Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol 134: 1152–1154
2. Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V (1987a) The acute-phase response after bisphosphonate administration. Calcif Tissue Int 41: 326–331
3. Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R, Lo Cacio V (1987b) The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy. Bone Miner 2: 395–404
4. Ahrengart L, Lindgren U (1986) Prevention of ectopic bone formation by local application of ethane-l-hydroxy-l,l-diphosphonate (EHDP): an experimental study in rabbits. J Orthop Res 4: 18–26
5. Alden CL, Parker R, Eastman DF (1989) Development of an acute model for the study of chloromethanediphosphonate nephrotoxicity. Toxicol Pathol 17: 27–32